Europe

French government replaces health products agency, gives additional powers

Wednesday, May 2, 2012 11:06 AM

The French government has replaced the French Food Safety Agency of Health Products with the new National Security Agency of Medicines and Health Products (MSNA).

More... »

Almac rewarded for excellence in technology

Monday, April 30, 2012 04:33 PM

Service provider Almac has been recognized for its technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (BMI).

More... »

Actelion's macitentan meets primary endpoint in phase III PAH study

Monday, April 30, 2012 12:10 PM

Switzerland-based Actelion Pharmaceuticals' initial analysis indicates that the pivotal, long-term phase III SERAPHIN study with macitentan, a novel dual endothelin receptor antagonist, has met its primary endpoint.

More... »

Pharmanest initiates phase I SHACT trial

Monday, April 30, 2012 11:45 AM

Pharmanest, a Stockholm-based pharmaceutical company, has dosed its first patient has in an open label pharmacokinetic phase I study with its drug candidate SHACT, a product developed for pain relief in connection with intrauterine device (IUD) insertion.

More... »

Europe approves Signifor, first drug for Cushing's disease

Wednesday, April 25, 2012 11:20 AM

The European Commission has approved Novartis’ Signifor (pasireotide) for the treatment of adult patients with Cushing's disease for whom surgery is not an option or for whom surgery has failed. Signifor is the first medicine to be approved in the E.U. targeting Cushing's disease.

More... »

Merck announces Swiss efficiency program, closure of Geneva office

Wednesday, April 25, 2012 10:05 AM

Global pharmaceutical and chemical company Merck Serono has announced efficiency plans for its Swiss operations as part of its comprehensive transformation program—focused on addressing unprecedented market shifts, increasing competition in key product areas and existing inefficiencies in its own organization.

More... »

Eisai partners with PharmaSwiss on chemo agent distribution

Monday, April 9, 2012 02:19 PM

Eisai Europe, the Tokyo-based subsidiary of Eisai, has entered into an agreement with PharmaSwiss, the Switzerland-based division of Valeant Pharmaceuticals International, to promote and distribute the Eisai's novel anticancer agent Halaven (eribulin mesylate) in a number of Central and Eastern European (CEE) countries.

More... »

British Prime Minister issues dementia challenge

Tuesday, March 27, 2012 02:13 PM

The Prime Minister has announced his commitment to make the U.K. a world leader in the fight against dementia.

More... »

GSK invests $794 million in U.K., creates jobs

Friday, March 23, 2012 12:44 PM

GlaxoSmithKline will invest more than $794 million in the U.K. across its manufacturing sites and a new facility in Cumbria to increase production of key active ingredients for its pharmaceutical products and vaccines, creating 1,000 new jobs.

More... »

Report: U.K. a leader in dementia research

Thursday, March 22, 2012 02:56 PM

The quality of dementia research in the U.K. is second only to the U.S., despite the low number of scientists working in this field, and finding a cure can be accelerated by increasing the number of dementia researchers and investment, according the Intellectual Property & Science business of Thomson Reuters. The findings are featured in an Alzheimer’s U.K. research report “Defeating Dementia.”

More... »